BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9856417)

  • 1. How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
    Diamanti-Kandarakis E
    J Endocrinol Invest; 1998 Oct; 21(9):623-9. PubMed ID: 9856417
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
    [No Abstract]   [Full Text] [Related]  

  • 5. Hirsutism - from diagnosis to use of antiandrogens.
    Unluhizarci K; Karaca Z; Kelestimur F
    Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiandrogen therapy in dermatology.
    Shaw JC
    Int J Dermatol; 1996 Nov; 35(11):770-8. PubMed ID: 8915726
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Finasteride and flutamide in the treatment of hirsutism].
    Falsetti L; De Fusco D; Rosina B
    Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome.
    Franks S
    Arch Dis Child; 1997 Jul; 77(1):89-90. PubMed ID: 9279164
    [No Abstract]   [Full Text] [Related]  

  • 11. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
    Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, low-dose flutamide does not cause hepatotoxicity in hyperandrogenic women.
    Legro RS
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):188-9. PubMed ID: 16932279
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
    De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome.
    Sahin I; Serter R; Karakurt F; Demirbas B; Guler S; Culha C; Taskapan C; Aral Y
    Horm Res; 2003; 60(5):232-6. PubMed ID: 14614228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hirsutes. II: Treatment.
    Young R; Sinclair R
    Australas J Dermatol; 1998 Aug; 39(3):151-7. PubMed ID: 9737040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.